Yoshii Y - Search Results

1

Regorafenib as a potential adjuvant chemotherapy agent in disseminated small colon cancer: Drug selection outcome of a novel screening system using nanoimprinting 3-dimensional culture with HCT116-RFP cells.

Yoshii Y, Furukawa T, Aoyama H, Adachi N, Zhang MR, Wakizaka H, Fujibayashi Y, Saga T. Yoshii Y, et al. Int J Oncol. 2016 Apr;48(4):1477-84. doi: 10.3892/ijo.2016.3361. Epub 2016 Jan 28. Int J Oncol. 2016. PMID: 26820693

2

High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.

Yoshii Y, Furukawa T, Waki A, Okuyama H, Inoue M, Itoh M, Zhang MR, Wakizaka H, Sogawa C, Kiyono Y, Yoshii H, Fujibayashi Y, Saga T. Yoshii Y, et al. Among authors: yoshii h. Biomaterials. 2015 May;51:278-289. doi: 10.1016/j.biomaterials.2015.02.008. Epub 2015 Feb 21. Biomaterials. 2015. PMID: 25771018

3

A limited overlap between intratumoral distribution of 1-(5-fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole and copper-diacetyl-bis[N(4)-methylthiosemicarbazone].

Furukawa T, Yuan Q, Jin ZH, Aung W, Yoshii Y, Hasegawa S, Endo H, Inoue M, Zhang MR, Fujibayashi Y, Saga T. Furukawa T, et al. Among authors: yoshii y. Oncol Rep. 2015 Sep;34(3):1379-87. doi: 10.3892/or.2015.4079. Epub 2015 Jun 25. Oncol Rep. 2015. PMID: 26134305

4

The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation.

Yoshii Y, Waki A, Yoshida K, Kakezuka A, Kobayashi M, Namiki H, Kuroda Y, Kiyono Y, Yoshii H, Furukawa T, Asai T, Okazawa H, Gelovani JG, Fujibayashi Y. Yoshii Y, et al. Among authors: yoshii h. Biomaterials. 2011 Sep;32(26):6052-8. doi: 10.1016/j.biomaterials.2011.04.076. Epub 2011 Jun 2. Biomaterials. 2011. PMID: 21640378

5

Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome.

Yoshii Y, Furukawa T, Oyama N, Hasegawa Y, Kiyono Y, Nishii R, Waki A, Tsuji AB, Sogawa C, Wakizaka H, Fukumura T, Yoshii H, Fujibayashi Y, Lewis JS, Saga T. Yoshii Y, et al. Among authors: yoshii h. PLoS One. 2013 May 31;8(5):e64570. doi: 10.1371/journal.pone.0064570. Print 2013. PLoS One. 2013. PMID: 23741342 Free PMC article.

6

Controlled administration of penicillamine reduces radiation exposure in critical organs during 64Cu-ATSM internal radiotherapy: a novel strategy for liver protection.

Yoshii Y, Matsumoto H, Yoshimoto M, Furukawa T, Morokoshi Y, Sogawa C, Zhang MR, Wakizaka H, Yoshii H, Fujibayashi Y, Saga T. Yoshii Y, et al. Among authors: yoshii h. PLoS One. 2014 Jan 22;9(1):e86996. doi: 10.1371/journal.pone.0086996. eCollection 2014. PLoS One. 2014. PMID: 24466309 Free PMC article.

7

Acetate/acetyl-CoA metabolism associated with cancer fatty acid synthesis: overview and application.

Yoshii Y, Furukawa T, Saga T, Fujibayashi Y. Yoshii Y, et al. Cancer Lett. 2015 Jan 28;356(2 Pt A):211-6. doi: 10.1016/j.canlet.2014.02.019. Epub 2014 Feb 22. Cancer Lett. 2015. PMID: 24569091 Review.

8

Comparison of intratumoral FDG and Cu-ATSM distributions in cancer tissue originated spheroid (CTOS) xenografts, a tumor model retaining the original tumor properties.

Furukawa T, Yuan Q, Jin ZH, Aung W, Yoshii Y, Hasegawa S, Endo H, Inoue M, Zhang MR, Fujibayashi Y, Saga T. Furukawa T, et al. Among authors: yoshii y. Nucl Med Biol. 2014 Sep;41(8):653-9. doi: 10.1016/j.nucmedbio.2014.05.139. Epub 2014 Jun 2. Nucl Med Biol. 2014. PMID: 24997088

9

(64)Cu-ATSM therapy targets regions with activated DNA repair and enrichment of CD133(+) cells in an HT-29 tumor model: Sensitization with a nucleic acid antimetabolite.

Yoshii Y, Furukawa T, Matsumoto H, Yoshimoto M, Kiyono Y, Zhang MR, Fujibayashi Y, Saga T. Yoshii Y, et al. Cancer Lett. 2016 Jun 28;376(1):74-82. doi: 10.1016/j.canlet.2016.03.020. Epub 2016 Mar 17. Cancer Lett. 2016. PMID: 26996296

10

Multiple Administrations of ⁶⁴Cu-ATSM as a Novel Therapeutic Option for Glioblastoma: a Translational Study Using Mice with Xenografts.

Yoshii Y, Matsumoto H, Yoshimoto M, Zhang MR, Oe Y, Kurihara H, Narita Y, Jin ZH, Tsuji AB, Yoshinaga K, Fujibayashi Y, Higashi T. Yoshii Y, et al. Transl Oncol. 2018 Feb;11(1):24-30. doi: 10.1016/j.tranon.2017.10.006. Epub 2017 Nov 17. Transl Oncol. 2018. PMID: 29154146 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

474 results

Search Page